NHS Consultant Chest Physician; Honorary Professor of Respiratory Medicine; Chief Clinical Officer INFEX Therapeutics: AMR & sustainable antimicrobial pipeline
Joined July 2019
- Tweets 106
- Following 758
- Followers 290
- Likes 1,299
1 Photos and videos
Jan 9
I am biased but this is a fabulous interstitial lung disease course. Best to get registered quickly as it is usually oversubscribed
Jan 9
Join as at the Manchester Interstitial Lung Diseases (MILD) 2026 on 26th/27th March @ConalHayton @LeonardColm @CristinaAvram8 @JBlaikley
Booking link below!
70
25 Nov 2025
Be wary of using @FedEx for deliveries from USA to UK. My new stethoscope arrived in UK one week ago & I still have not received it. FedEx live chat & phone numbers do not allow human conversation! Appalling service
10
1
162
27 Oct 2025
Beware flying with @FlyLoganair as my Wife experiencing terrible customer service Manchester to Aberdeen . Flew yesterday to Aberdeen, no baggage put on plane, told it would be on following flight, 2 flights later bag still in Manchester. Loganair unhelpful as is handling agent
1
1
317
21 May 2025
Very excited to work with Asian ADVANCE-ID network to plan clinical trials of our novel metallo-beta-lactamase (MBL) inhibitor, MET-X. Antimicrobials targeting MBL mechanism of Gram negative bacterial resistance to antibiotics is key gap in pipeline. @davidantibiotic @INFEX_TX
21 May 2025
Infex agrees collaboration with Asian clinical trials network, ADVANCE-ID
Memorandum of Understanding signed to investigate hospital-acquired drug-resistant infections in Asia:
infextx.com/infex-agrees-colā¦
1
6
16
745
25 Feb 2025
Excited to share our licensing deal in India for clinical development of MET-X our novel metallobetalactamase (MBL) inhibitor. MBL mechanism of resistance is an enormous problem in India & SE Asia & a rising problem EU & USA. MBL mechanism is a key pipeline priority for WHO
25 Feb 2025
Infex signs exclusive license agreement with Venus Remedies Ltd to advance MET-X through clinical development and commercialisation in India:
infextx.com/infex-signs-exclā¦
2
159
17 Feb 2025
Novel pathways to combat antimicrobial resistance sorely needed. Its super that with this PACE funding INFEX & the team at Justus-Liebig-University Giessen can now advance this exciting BamA inhibitor project towards clinical trial readiness
17 Feb 2025
Infex and Justus-Liebig-University Giessen awarded Ā£1 million grant from PACE:
infextx.com/infex-and-justusā¦
5
13
724
colm leonard retweeted
š New data from @UKHSA: Antibiotic-resistant infections in 2023 exceeded pre-pandemic levels
An alarming 66,730 serious cases were reported - compared to 62,314 in 2019.
šgov.uk/government/news/antibā¦
8
8
532
27 Nov 2024
This is scary, warzone superbugs come to visit! Funders, regulators, HTA entities need to facilitate antibiotic pipeline to have necessary armoury to fight this threat. Antimicrobial resistance is not a silent threat. Antimicrobial BioTech needs support harvardpublichealth.org/globā¦
4
127
3 Feb 2024
Looks like a super programme, thanks for sharing Chris.
2 Feb 2024
Looking forward to chairing the Antimicrobial Chemotherapy Conference next week (6-7th Feb). It's a free virtual meeting organised jointly by GARDP and BSAC with an exciting programme covering the whole antimicrobial development pathway. Register Here: acc-conference.com/2023-confā¦
5
311
colm leonard retweeted
8 Aug 2023
š£ @INFEX_TX is on a mission to combat new COVID strains and is searching for a global pharma partner.
Read more about their new treatment for COVID variants below ā¬ļø bit.ly/45jwo5H
2
4
430
colm leonard retweeted
8 Aug 2023
Infex Therapeutics Clinical candidate nominated for COV-X programme
šCOV-X outperforms Pfizer's approved antiviral
šUnique target: potential for broad efficacy against new coronaviruses
š¦ Emerging resistance to existing Mpro inhibitors
infextx.com/clinical-candidaā¦
#COVID19
3
6
674
30 Jun 2023
Alarming antibiotic resistance discovered in war-torn Ukraine- this is truly frightening, the not so silent pandemic of AMR, 10% resistance to Colistin! medicalxpress.com/news/2023-ā¦
3
11
535
colm leonard retweeted
We are recruiting healthy volunteers for a trial with @INFEX_TX. The full details are below š
Contact us to find out how you can #GetInvolvedinResearch
@LivHospitalsRI @LivHospitals
3
3
448
colm leonard retweeted
11 Feb 2023
Questions about the UK Subscription Program for Antibacterials? See our Open Access article out today. Kudos to Team UK for leading the world. link.springer.com/article/10ā¦
w @JohnRex_NewAbx
2
18
37
8,290
17 Jan 2023
Can the UK 'Netflix' Payment Model Boost the Antibacterial Pipeline? - PubMed pubmed.ncbi.nlm.nih.gov/3664ā¦
10
17
3,335
colm leonard retweeted
17 Jan 2023
'Can the UK's Netflix payment model boost the antibacterial pipeline?'
Great insights on the how the project was devised & developed - sharing lessons learned - from @LeonardColm and team:
pubmed.ncbi.nlm.nih.gov/3664ā¦
#pullincentives #antibioticresistance #innovation
17 Jan 2023
Delighted to share our publication on the NICE & NHS England project to deliver novel value assessment & reimbursement for new antimicrobial ā¦@NICECommsā© ā¦@NHSEnglandā© trebuchet.public.springernatā¦
1
261
17 Jan 2023
Delighted to share our publication on the NICE & NHS England project to deliver novel value assessment & reimbursement for new antimicrobial ā¦@NICECommsā© ā¦@NHSEnglandā© trebuchet.public.springernatā¦
1
2
4
814
5 Jan 2023
RT @PilarRiveraOrt1: šØ Northern Ireland and ManchesterĀ Interstitial Lung Disease Course which will be held onĀ 2nd -3rd March 2023 šØ #Mancheā¦
9
9 Dec 2022
Very proud of Lucy judging ice dance Grand Prix final in Turin
3